#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15554	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2074	746.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1436	1436	C	936	C	862	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27526	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3550	773.7	0	.	n	.	0	A20C	SNP	20	20	A	333	333	C	518	C	491	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27526	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3550	773.7	0	.	n	.	0	T695C	SNP	695	695	T	1008	1008	C	823	C	774	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27526	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3550	773.7	0	.	n	.	0	A1638G	SNP	1638	1638	A	1951	1951	G	968	G,A	897,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27526	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3550	773.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2284	2284	C	893	C,T,A,G	824,1,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27526	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3550	773.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2358	2358	A	888	A,G	812,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27526	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3550	773.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2910	2910	C	931	C	856	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2100	folP	855	855	100.0	folP.l15.c17.ctg.1	1521	137.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1063	1065	AGC	230;228;230	A;G;C	215;213;213	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5548	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3427	161.4	1	SNP	p	S91F	1	.	.	271	273	TTC	565	567	TTC	191;190;191	T;T,C;C	179;176,1;177	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5548	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3427	161.4	1	SNP	p	D95G	1	.	.	283	285	GGC	577	579	GGC	186;190;189	G;G;C	169;174;176	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5548	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3427	161.4	1	SNP	p	G95N	0	.	.	283	285	GGC	577	579	GGC	186;190;189	G;G;C	169;174;176	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1668	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1365	122.0	1	SNP	p	G45D	0	.	.	133	135	GGC	430	432	GGC	226;226;225	G;G;C	207;208;207	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	798	mtrR_promoter	250	250	99.2	mtrR_promoter.l6.c17.ctg.1	927	85.5	0	.	n	.	0	G98A	SNP	98	98	G	450	450	A	192	A	177	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	798	mtrR_promoter	250	250	99.2	mtrR_promoter.l6.c17.ctg.1	927	85.5	0	.	n	.	0	A197.	DEL	197	197	A	548	548	A	217	A	202	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5428	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2880	187.7	1	SNP	p	D86N	0	.	.	256	258	GAC	499	501	GAC	201;200;203	G;A;C	183;180;189	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5428	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2880	187.7	1	SNP	p	R87I	0	.	.	259	261	CGT	502	504	CGT	205;204;205	C;G;T	194;192;192	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5428	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2880	187.7	1	SNP	p	S87R	1	.	.	259	261	CGT	502	504	CGT	205;204;205	C;G;T	194;192;192	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5428	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2880	187.7	1	SNP	p	R87W	0	.	.	259	261	CGT	502	504	CGT	205;204;205	C;G;T	194;192;192	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5428	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2880	187.7	1	SNP	p	S88P	0	.	.	262	264	TCC	505	507	TCC	207;205;205	T;C;C	196;192;194	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4420	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2600	169.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1483	1485	GGC	226;224;221	G;G;C	207;204;200	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4332	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2369	182.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1249	1251	GCA	257;256;259	G;C;A	232;232;236	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4332	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2369	182.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1252	1254	ATC	259;259;259	A;T;C	234;233;234	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4332	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2369	182.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1264	1266	GTG	265;262;262	G;T;G	236;237;236	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4332	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2369	182.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1264	1266	GTG	265;262;262	G;T;G	236;237;236	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4332	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2369	182.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1768	1770	ACC	247;248;250	A;C;C	219;221;224	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4332	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2369	182.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1822	1824	GCG	232;232;230	G;C;G	203;178;193	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4332	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2369	182.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1822	1824	GCG	232;232;230	G;C;G	203;178;193	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4332	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2369	182.1	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1945	1947	AGC	185;185;186	A,G;G;C	170,1;170;171	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4332	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2369	182.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1954	1956	GGC	182;180;181	G;G;C	170;167;164	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4332	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2369	182.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1972	1974	CCG	156;164;164	C,G;C,G;G	121,2;129,1;128	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6254	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3109	200.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1661	1663	CCG	234;236;236	C;C;G,A	197;207;202,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2438	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1792	135.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	541	541	C	179	C	163	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3088	porB1b	1047	1047	98.47	porB1b.l15.c4.ctg.1	1447	212.5	0	.	p	.	0	N38E	NONSYN	112	114	AAT	371	373	GAA	248;245;241	G;A;A	226;225;223	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3088	porB1b	1047	1047	98.47	porB1b.l15.c4.ctg.1	1447	212.5	0	.	p	.	0	K41D	NONSYN	121	123	AAA	380	382	GAC	243;248;246	G;A;C	224;227;229	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3088	porB1b	1047	1047	98.47	porB1b.l15.c4.ctg.1	1447	212.5	0	.	p	.	0	K120N	NONSYN	358	360	AAG	617	619	AAT	280;281;282	A;A;T	256;257;257	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3088	porB1b	1047	1047	98.47	porB1b.l15.c4.ctg.1	1447	212.5	0	.	p	.	0	P175S	NONSYN	523	525	CCA	782	784	TCA	263;262;261	T;C;A	241;242;242	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3088	porB1b	1047	1047	98.47	porB1b.l15.c4.ctg.1	1447	212.5	0	.	p	.	0	D212trunc	TRUNC	634	634	G	893	893	G	262	G	244	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3088	porB1b	1047	1047	98.47	porB1b.l15.c4.ctg.1	1447	212.5	0	.	p	.	0	A218V	NONSYN	652	654	GCC	908	910	GTC	252;253;254	G,A;T;C,G	239,1;240;241,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3088	porB1b	1047	1047	98.47	porB1b.l15.c4.ctg.1	1447	212.5	0	.	p	.	0	A242V	NONSYN	724	726	GCC	980	982	GTT	243;241;241	G;T;T	230;229;229	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3088	porB1b	1047	1047	98.47	porB1b.l15.c4.ctg.1	1447	212.5	1	SNP	p	D121N	0	.	.	361	363	GAC	620	622	GAC	283;280;282	G;A;C	259;256;258	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3088	porB1b	1047	1047	98.47	porB1b.l15.c4.ctg.1	1447	212.5	1	SNP	p	A121D	1	.	.	361	363	GAC	620	622	GAC	283;280;282	G;A;C	259;256;258	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11142	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4815	230.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1142	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	954	118.6	1	SNP	p	V57M	1	.	.	169	171	ATG	438	440	ATG	225;227;226	A;T;G	213;217;215	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
